Our CEO, Yishai Knobel was recently interviewed by Sara Gilgore, a staff writer for the Washington Business Journal about the evolution of RxWare, the name change from HelpAround, and where he sees the future of the company and its mission to make it easier for patients to access and adhere to medication. … Read More
We are excited to announce that starting today HelpAround is RxWare.
When we began our journey years ago, it was as a company on a mission to simplify patients’ lives, initially by providing a support network for type-1 diabetes families. While our mission has not changed, we pursue it today by enabling specialty drug manufacturers to do the same by simplifying therapy onboarding for patients. … Read More
An inflection point now faces the specialty pharmaceutical industry. Along their journey, specialty pharma patients interact with a series of siloed institutions: clinics, specialty pharmacies, copay program vendors, patient assistance programs, nurses, etc. Not unlike the financial industry, these institutions still exchange patient information via fax machines. … Read More
Our founder, Yishai Knobel was recently featured on the Empowered Patient Podcast with Karen Jagoda where he talked all things specialty and how the HelpAround gateway is helping patients get their drugs faster and stay on therapy longer. … Read More
Imagine visiting your doctor’s office. Instead of swiping a co-pay card and filling out a paper form by hand, the receptionist says, “Please bring your phone closer. We take Apple Health here.” You wave your iPhone over a digital kiosk, instantly uploading your current medical record and insurance information. Your co-pay is then deducted from a Health Savings Account. Voila! The doctor will see you now. … Read More
Our founder, Yishai Knobel was recently interviewed by Fotis Georgiadis, a staff writer for Authority Magazine, a Medium publication, devoted to sharing in-depth, and interesting interviews, featuring people who are authorities in Business, Pop Culture, Wellness, Social Impact, and Tech. … Read More
